Subq njx filling matrl 1cc/<
G0429 identifies therapeutic filler treatment for facial lipodystrophy. Code 11950 is a general filling-material injection code selected by volume, rather than by this specific diagnosis.
CMS RVU26D · Effective 2026-10-01
Reports injectable filler treatment to restore facial soft-tissue volume lost through facial lipodystrophy, including lipoatrophy associated with HIV therapy. Compare G0429 office and facility rates across CMS payment localities in Pennsylvania.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
Pennsylvania has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
$94.67–$103.38
2 of 2 localities have a supported rate.
$54.81–$58.18
2 of 2 localities have a supported rate.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Dermatology procedure
Reports injectable filler treatment to restore facial soft-tissue volume lost through facial lipodystrophy, including lipoatrophy associated with HIV therapy.
G0429 is for injecting dermal filler to address facial volume loss from facial lipodystrophy, such as sunken cheeks associated with HIV treatment. Dermatologists and plastic surgeons commonly perform the injections in an office setting, placing filler into affected facial soft tissue to improve contour. The code is specific to this therapeutic indication, not simply to the use of filler for cosmetic enhancement.
The record should identify facial lipodystrophy, the treated areas, the medical reason for treatment, and the injection service. This is a minor procedure with a 0-day global period, so same-day preoperative and postoperative care is included. When multiple procedures are performed in the same session, the highest-valued procedure is paid in full and other procedures are subject to the standard 50% multiple-procedure reduction. Modifier 50 is inappropriate. Assistant-at-surgery payment requires documented medical necessity; co-surgeons and team surgery are not permitted.
760
Medicare services in 2024 · #3201 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Office rates for Pennsylvania, from the same CMS release.
Subq njx filling matrl 1cc/<
G0429 identifies therapeutic filler treatment for facial lipodystrophy. Code 11950 is a general filling-material injection code selected by volume, rather than by this specific diagnosis.
Subq njx fil matrl 5.1-10cc
G0429 is specific to treatment of facial lipodystrophy; 11952 is a general filler-injection code associated with a different injected-volume range.
Subq njx fil matrl>10.0 cc
Use G0429 for filler treatment of facial lipodystrophy. Code 11954 is a general volume-based filler code for a different volume circumstance.
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Office / nonfacility
$103.38
Facility
$58.18
Office / nonfacility
$94.67
Facility
$54.81
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
Use G0429 for filler treatment of facial lipodystrophy, including facial volume loss associated with HIV therapy. General filler-injection codes are organized around injected volume and are not specific to this indication.
Document the facial lipodystrophy diagnosis, the affected facial areas, the medical reason for treatment, and the injection performed. The record should distinguish therapeutic restoration of lost facial volume from cosmetic enhancement.
G0429 has a 0-day global period, and same-day preoperative and postoperative care is included in the procedure.
No. The CMS bilateral adjustment does not apply, and modifier 50 is inappropriate for this code.
When G0429 is performed with other procedures in the same session, the highest-valued procedure is paid in full and the others are subject to the standard 50% reduction.
Assistant-at-surgery payment is allowed only when medical necessity is documented. Co-surgeons and team surgery are not permitted.
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.